Who owns HAEMONETICS?
- CUSIP Number: 405024ab6
Tip: Access positions for across all investors
Analyze quarterly positions in Haemonetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Haemonetics stock
Who bought or sold HAEMONETICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 66M | $61B | 120% | Mar 2024 |
|
| Franklin Resources | 50M | $46M | 0% | Mar 2024 |
|
| Bank Of Montreal | 35M | $32M | 100% | Mar 2024 |
|
| Readystate Asset Management | 33M | $30M | 0% | Mar 2024 |
|
| MacKay Shields | 28M | $26M | -1% | Mar 2024 |
|
| DeepCurrents Investment Group | 26M | $24M | 0% | Mar 2024 |
|
| Aviva | 24M | $22M | 6% | Mar 2024 |
|
| Braidwell | 22M | $20M | 100% | Mar 2024 |
|
| Osterweis Capital Management | 18M | $17M | 0% | Mar 2024 |
|
| Wells Fargo & Company | 17M | $16M | -12% | Mar 2024 |
|
| Citadel Advisors | 12M | $11M | 100% | Mar 2024 |
|
| Verition Fund Management | 8.3M | $7.7M | 44302% | Mar 2024 |
|
| New York State Common Retirement Fund | 6.6M | $6.1M | 39% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 6.0M | $5.5M | 0% | Mar 2024 |
|
| BlackRock | 4.4M | $4.0M | 47% | Mar 2024 |
|
| SSI Investment Management | 4.1M | $3.7M | -62% | Dec 2023 |
|
| Citigroup | 3.0M | $2.8M | 10643% | Mar 2024 |
|
| Russell Investments | 2.8M | $2.6M | 6% | Mar 2024 |
|
| Wellesley Investment Advisors | 2.5M | $2.3B | -11% | Dec 2023 |
|
| Aequim Alternative Investments | 2.5M | $2.3M | -88% | Mar 2024 |
|
| Kohlberg Kravis Roberts & Co | 2.3M | $2.1M | -27% | Mar 2024 |
|
| Ontario Teachers' Pension Plan Board | 2.0M | $1.8M | 0% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 2.0M | $1.8M | 0% | Mar 2024 |
|
| Barclays | 1.3M | $1.2M | 29% | Mar 2024 |
|
| Quaero Capital | 1.2M | $1.1M | 0% | Mar 2024 |
|
| Corbyn Investment Management | 510k | $468k | 0% | Mar 2024 |
|
| American Century Companies | 359k | $331k | 122% | Mar 2024 |
|
| Sei Investments | 335k | $308k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 300k | $276k | 0% | Mar 2024 |
|
| Calamos Advisors | 294k | $272k | 0% | Mar 2024 |
|
| Oppenheimer Asset Management | 130k | $119k | -43% | Mar 2024 |
|
| Stephens | 118k | $108k | 127% | Mar 2024 |
|
| Beacon Investment Advisors | 64k | $59k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 49k | $45k | -92% | Mar 2024 |
|
| Virtus Investment Advisers | 41k | $38k | 0% | Mar 2024 |
|
| Balboa Wealth Partners | 38k | $35k | -5% | Mar 2024 |
|
| Zazove Associates | 22k | $20k | 0% | Mar 2024 |
|
| Leucadia National Corporation | 16k | $15k | -99% | Mar 2024 |
|
| Royal Bank of Canada | 14k | $13k | 100% | Mar 2024 |
|
| Context Capital Management | 6.1k | $5.6M | -100% | Mar 2024 |
|
| Brown Trout Management | 2.3k | $2.1M | 100% | Mar 2024 |
|
Who sold out of Haemonetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 51M | $44B |
| Wolverine Asset Management | Dec 2023 | 25M | $23M |
| Empyrean Capital Partners | Dec 2023 | 16M | $14M |
| D. E. Shaw & Co | Dec 2023 | 12M | $11M |
| Agf Management | Dec 2023 | 1.9M | $1.6M |
| Aurum Wealth Management Group | Sep 2023 | 13k | $11k |